Results 61 to 70 of about 23,474 (233)

Effectiveness of Oral Bupropion and Nortriptyline as an Adjunct Treatment for Reducing the Use of Smokeless Tobacco: A Retrospective Study from a Tobacco Cessation Clinic in a Tertiary Care Hospital in Eastern India

Indian Journal of Public Health
Background: There is supporting evidence on the use of nortriptyline in smoking; however, its effectiveness in smokeless tobacco cessation has not been studied. Objectives: The objectives of this study were to evaluate the effectiveness of oral bupropion
Aparajita Guin, Hoineiting Rebecca Haokip, Sanjib Bandyopadhyay, Saibal Das, Indranil Saha, Aniruddha Basu, Stuti Bhargava   +6 more
doaj   +1 more source

Delayed allergic reaction from bupropion in a 27-year-old male with MDD: A case report and literature review [PDF]

Mental Health Clinician
Introduction Bupropion is an antidepressant approved for the treatment of major depressive disorder (MDD), seasonal affective disorder, and smoking cessation. Nausea, headache, tremor, and insomnia are well-known adverse effects of this medication.
Ana Anghel, BSc(Psych), G. Lucy Wilkening, PharmD   +1 more
doaj   +1 more source

Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map

Addiction, EarlyView.
Abstract Background and aims Electronic cigarettes (EC) are considered a smoking cessation tool in some countries, such as the United Kingdom, but uncertainty remains internationally over whether their benefits outweigh potential harms when used for this purpose.
Angela Difeng Wu, Monserrat Conde, Ailsa R. Butler, Ethan Knight, Nicola Lindson, Jonathan Livingstone‐Banks, Peter Hajek, Hayden McRobbie, Rachna Begh, Annika Theodoulou, Caitlin Notley, Tari Turner, Eliza Zhitnik, Jamie Hartmann‐Boyce   +13 more
wiley   +1 more source

Rapid bupropion-induced hepatotoxicity: a case report and review of the literature

Journal of Medical Case Reports, 2018
Background Bupropion is an antidepressant that is also used as a non-nicotine method to aid in smoking cessation. Bupropion-induced hepatotoxicity is quoted to affect between 0.1% and 1% of treated patients with either a hepatocellular and/or cholestatic
Sulakchanan Anandabaskaran, Vincent Ho
doaj   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Bupropion for the Treatment of ADHD [PDF]

, 2020
Purpose: The purpose of this article is to review the efficacy of treating Attention Deficit Hyperactivity Disorder (ADHD) in the outpatient setting with bupropion.
Hile, Amanda L
core  

The association between sleep disturbance and stimulant use: A cross‐lagged examination

Addiction, EarlyView.
Abstract Background and aims Sleep disruptions increase the risk of substance misuse. Substance use—especially stimulants—can increase acute and chronic sleep dysfunction. This study aimed to estimate the associations between sleep disturbance and stimulant use over time among participants with stimulant use disorder (StUD).
Viviana E. Horigian, Renae D. Schmidt, Daniel J. Feaster, Rui Duan, Sophia T. Gonzalez, Kathryn Hefner, Dikla Shmueli‐Blumberg, Ashley Vena, Landhing M. Moran, Chloe A. DiCamillo, Shirin Shafazand, Susan Tross, Judith Feinberg   +12 more
wiley   +1 more source

A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder [PDF]

, 2014
Narong Maneeton,1 Benchalak Maneeton,1 Suthi Intaprasert,1 Pakapan Woottiluk2 1Department of Psychiatry, Faculty of Medicine, 2Psychiatric Nursing Division, Faculty of Nursing, Chiang Mai University, Chiang Mai, ThailandBackground: Some ...
Maneeton B, Maneeton N, Woottiluk P, Intaprasert S   +3 more
core  

The Efficacy and Toxicity of Bupropion in the Elderly [PDF]

, 2012
Bupropion is an antidepressant with excellent tolerability and few side effects or drug interactions. These characteristics suite it well for use both in the elderly and in the medically ill.
Warnock, Julia K., M.D., Ph.D., Howard, William T., M.D., M.S.   +1 more
core   +2 more sources

Acute dystonia after single dose of bupropion

Indian Journal of Psychological Medicine, 2016
Bupropion is an antidepressant that is effective in the treatment of major depressive disorders, smoking cessation, and sexual side effects of selective serotonin reuptake inhibitors.
Forouzan Elyasi, Elham Mahtiyan
doaj   +1 more source